Skip to main content
Year archive

X BIOSCIENCE PUBLIC COMPANY LIMITED — 2021 filings

All 20 regulatory filings released by X BIOSCIENCE PUBLIC COMPANY LIMITED (XBIO) in 2021, sourced directly from the official regulator.

20 Filings
2021 Period
2021 filings (20)
Filing Released Lang
Notification on Resignation of Director of the Company
Board/Management Information
2021-12-21 English
Additional Clarification on Big Lot Transaction
Major Shareholding Notification
2021-12-13 English
Resignation of (Acting) Chief Executive Officer (Revised)
Board/Management Information
2021-12-13 English
Resignation of (Acting) Chief Executive Officer
Board/Management Information
2021-12-13 English
Change to the Shareholding Structure of Major Shareholder and the Resignation of Director and (Acting) Chief Executive Officer
Major Shareholding Notification
2021-12-09 English
Clarification on Big Lot Transaction
Regulatory Filings
2021-12-07 English
Announcement of Public Holidays 2022
Regulatory Filings
2021-11-30 English
The Entry into the Connected Transaction, in a Category of the Receipt of Financial Assistance
Capital/Financing Update
2021-11-15 English
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021
Management Reports
2021-11-15 English
Financial Performance Quarter 3 (F45) (Reviewed)
Report Publication Announcement
2021-11-15 English
Financial Statement Quarter 3/2021 (Reviewed)
Regulatory Filings
2021-11-15 English
Invitation to Shareholders to Propose Agenda Items and Nominate Candidates for Directorship for the AGM 2022
Regulatory Filings
2021-11-02 English
Notification of the Resignation of the Company Secretary
Board/Management Information
2021-10-27 English
C sign lifted on listed companies
Regulatory Filings
2021-08-17 English
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021 (revised and inserted information)
Management Reports
2021-08-17 English
Financial Performance Quarter 2 (F45) (Reviewed)
Regulatory Filings
2021-08-17 English
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021
Management Reports
2021-08-16 English
Financial Performance Quarter 2 (F45) (Reviewed)
Report Publication Announcement
2021-08-16 English
Financial Statement Quarter 2/2021 (Reviewed)
Regulatory Filings
2021-08-16 English
Report on utilization of proceeds from capital increase by private placement (PP) and capital increase from conversion rights (W-W3)
Regulatory Filings
2021-07-30 English